Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis? (2022)

Objective: The aim of this study was to compare patients with ankylosing spondylitis with psoriasis (ASP) and without psoriasis (AS), to axial PsA (axPsA) patients. Methods: Two adult cohorts were recruited from the AS clinic: ASP and AS. These two cohorts were compared with two adult cohorts recruited from the PsA clinic: axPsA (radiographic sacroiliitis: ≥bilateral grade 2 or unilateral grade 3 or 4); and Peripheral PsA. All patients were followed prospectively according to the same protocol. The demographic, clinical and radiographic variables were compared. Adjusted means were used to account for varying intervals between visits. A logistic regression was performed and adjusted for follow-up duration. Results: There were 477 axPsA patients, 826 peripheral PsA, 675 AS and 91 ASP patients included. AS patients were younger (P < 0.001), more male and HLA-B∗27 positive (76%, 72% vs 64%, P ≤ 0.001, 82%, 75%, vs 19%, P = 0.001). They had more back pain at presentation (90%, 92% vs 19%, P = 0.001), worse axial disease activity scores (bath ankylosing spondylitis disease activity index: 4.1, 3.9 vs 3.5 P = 0.017), worse back metrology (bath ankylosing spondylitis metrology index: 2.9, 2.2 vs 1.8, P < 0.001), worse physician global assessments (2.4, 2.2 vs 2.1, P < 0.001), were treated more with biologics (29%, 21% vs 7%, P = 0.001) and had a higher grade of sacroiliitis (90%, 84% vs 51%, P < 0.001). Similar differences were detected in the comparison of ASP to axPsA and in a regression model. Conclusion: AS patients, with or without psoriasis, seem to be different demographically, genetically, clinically and radiographically from axPsA patients. axPsA seems to be a distinct entity.

Original languageEnglish
Pages (from-to)1340-1346
Number of pages7
JournalRheumatology
Volume59
Issue number6
DOIs
Publication statusPublished - 1 Jun 2020

Funding Information:
The University of Toronto Psoriatic Arthritis Program is supported by a grant from the Krembil Foundation. J.F. was supported by a grant from Novartis. All authors were involved in drafting the article or revising it critically for important intellectual content, and all authors approved the final version to be published. All authors were likewise involved in the study conception and design, acquisition of data as well as analysis and interpretation of data. D.D.G. had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Publisher Copyright:
© 2019 The Author(s). Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved.

  • ankylosing
  • arthritis
  • axial
  • psoriatic
  • spondylitis
  • APA
  • Author
  • BIBTEX
  • Harvard
  • Standard
  • RIS
  • Vancouver

Feld, J., Ye, J. Y., Chandran, V., Inman, R. D., Haroon, N., Cook, R., & Gladman, D. D. (2020). Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis? Rheumatology, 59(6), 1340-1346. https://doi.org/10.1093/rheumatology/kez457

(Video) Expert Recommendations from EULAR on Psoriatic Arthritis/Ankylosing Spondylitis/Miscellaneous

Feld, Joy ; Ye, Justine Yang ; Chandran, Vinod ; Inman, Robert D. ; Haroon, Nigil ; Cook, Richard ; Gladman, Dafna D. / Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?. In: Rheumatology. 2020 ; Vol. 59, No. 6. pp. 1340-1346.

@article{f42d60c0a1e544098475bb6042684281,

title = "Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?",

abstract = "Objective: The aim of this study was to compare patients with ankylosing spondylitis with psoriasis (ASP) and without psoriasis (AS), to axial PsA (axPsA) patients. Methods: Two adult cohorts were recruited from the AS clinic: ASP and AS. These two cohorts were compared with two adult cohorts recruited from the PsA clinic: axPsA (radiographic sacroiliitis: ≥bilateral grade 2 or unilateral grade 3 or 4); and Peripheral PsA. All patients were followed prospectively according to the same protocol. The demographic, clinical and radiographic variables were compared. Adjusted means were used to account for varying intervals between visits. A logistic regression was performed and adjusted for follow-up duration. Results: There were 477 axPsA patients, 826 peripheral PsA, 675 AS and 91 ASP patients included. AS patients were younger (P < 0.001), more male and HLA-B∗27 positive (76%, 72% vs 64%, P ≤ 0.001, 82%, 75%, vs 19%, P = 0.001). They had more back pain at presentation (90%, 92% vs 19%, P = 0.001), worse axial disease activity scores (bath ankylosing spondylitis disease activity index: 4.1, 3.9 vs 3.5 P = 0.017), worse back metrology (bath ankylosing spondylitis metrology index: 2.9, 2.2 vs 1.8, P < 0.001), worse physician global assessments (2.4, 2.2 vs 2.1, P < 0.001), were treated more with biologics (29%, 21% vs 7%, P = 0.001) and had a higher grade of sacroiliitis (90%, 84% vs 51%, P < 0.001). Similar differences were detected in the comparison of ASP to axPsA and in a regression model. Conclusion: AS patients, with or without psoriasis, seem to be different demographically, genetically, clinically and radiographically from axPsA patients. axPsA seems to be a distinct entity. ",

keywords = "ankylosing, arthritis, axial, psoriatic, spondylitis",

author = "Joy Feld and Ye, {Justine Yang} and Vinod Chandran and Inman, {Robert D.} and Nigil Haroon and Richard Cook and Gladman, {Dafna D.}",

note = "Funding Information: The University of Toronto Psoriatic Arthritis Program is supported by a grant from the Krembil Foundation. J.F. was supported by a grant from Novartis. All authors were involved in drafting the article or revising it critically for important intellectual content, and all authors approved the final version to be published. All authors were likewise involved in the study conception and design, acquisition of data as well as analysis and interpretation of data. D.D.G. had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Publisher Copyright: {\textcopyright} 2019 The Author(s). Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved.",

year = "2020",

month = jun,

day = "1",

doi = "10.1093/rheumatology/kez457",

language = "English",

(Video) Psoriatic spondyloarthritis or ankylosing spondylitis with psoriasis Similarities

volume = "59",

pages = "1340--1346",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "6",

}

Feld, J, Ye, JY, Chandran, V, Inman, RD, Haroon, N, Cook, R & Gladman, DD 2020, 'Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?', Rheumatology, vol. 59, no. 6, pp. 1340-1346. https://doi.org/10.1093/rheumatology/kez457

Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis? / Feld, Joy; Ye, Justine Yang; Chandran, Vinod; Inman, Robert D.; Haroon, Nigil; Cook, Richard; Gladman, Dafna D.

In: Rheumatology, Vol. 59, No. 6, 01.06.2020, p. 1340-1346.

Research output: Contribution to journalArticle (Contribution to journal)peer-review

TY - JOUR

(Video) Early Identification and Diagnosis of Axial Spondyloarthritis - Philip Mease, M.D.

T1 - Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?

AU - Feld, Joy

AU - Ye, Justine Yang

AU - Chandran, Vinod

AU - Inman, Robert D.

AU - Haroon, Nigil

AU - Cook, Richard

AU - Gladman, Dafna D.

N1 - Funding Information:The University of Toronto Psoriatic Arthritis Program is supported by a grant from the Krembil Foundation. J.F. was supported by a grant from Novartis. All authors were involved in drafting the article or revising it critically for important intellectual content, and all authors approved the final version to be published. All authors were likewise involved in the study conception and design, acquisition of data as well as analysis and interpretation of data. D.D.G. had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.Publisher Copyright:© 2019 The Author(s). Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved.

PY - 2020/6/1

Y1 - 2020/6/1

N2 - Objective: The aim of this study was to compare patients with ankylosing spondylitis with psoriasis (ASP) and without psoriasis (AS), to axial PsA (axPsA) patients. Methods: Two adult cohorts were recruited from the AS clinic: ASP and AS. These two cohorts were compared with two adult cohorts recruited from the PsA clinic: axPsA (radiographic sacroiliitis: ≥bilateral grade 2 or unilateral grade 3 or 4); and Peripheral PsA. All patients were followed prospectively according to the same protocol. The demographic, clinical and radiographic variables were compared. Adjusted means were used to account for varying intervals between visits. A logistic regression was performed and adjusted for follow-up duration. Results: There were 477 axPsA patients, 826 peripheral PsA, 675 AS and 91 ASP patients included. AS patients were younger (P < 0.001), more male and HLA-B∗27 positive (76%, 72% vs 64%, P ≤ 0.001, 82%, 75%, vs 19%, P = 0.001). They had more back pain at presentation (90%, 92% vs 19%, P = 0.001), worse axial disease activity scores (bath ankylosing spondylitis disease activity index: 4.1, 3.9 vs 3.5 P = 0.017), worse back metrology (bath ankylosing spondylitis metrology index: 2.9, 2.2 vs 1.8, P < 0.001), worse physician global assessments (2.4, 2.2 vs 2.1, P < 0.001), were treated more with biologics (29%, 21% vs 7%, P = 0.001) and had a higher grade of sacroiliitis (90%, 84% vs 51%, P < 0.001). Similar differences were detected in the comparison of ASP to axPsA and in a regression model. Conclusion: AS patients, with or without psoriasis, seem to be different demographically, genetically, clinically and radiographically from axPsA patients. axPsA seems to be a distinct entity.

AB - Objective: The aim of this study was to compare patients with ankylosing spondylitis with psoriasis (ASP) and without psoriasis (AS), to axial PsA (axPsA) patients. Methods: Two adult cohorts were recruited from the AS clinic: ASP and AS. These two cohorts were compared with two adult cohorts recruited from the PsA clinic: axPsA (radiographic sacroiliitis: ≥bilateral grade 2 or unilateral grade 3 or 4); and Peripheral PsA. All patients were followed prospectively according to the same protocol. The demographic, clinical and radiographic variables were compared. Adjusted means were used to account for varying intervals between visits. A logistic regression was performed and adjusted for follow-up duration. Results: There were 477 axPsA patients, 826 peripheral PsA, 675 AS and 91 ASP patients included. AS patients were younger (P < 0.001), more male and HLA-B∗27 positive (76%, 72% vs 64%, P ≤ 0.001, 82%, 75%, vs 19%, P = 0.001). They had more back pain at presentation (90%, 92% vs 19%, P = 0.001), worse axial disease activity scores (bath ankylosing spondylitis disease activity index: 4.1, 3.9 vs 3.5 P = 0.017), worse back metrology (bath ankylosing spondylitis metrology index: 2.9, 2.2 vs 1.8, P < 0.001), worse physician global assessments (2.4, 2.2 vs 2.1, P < 0.001), were treated more with biologics (29%, 21% vs 7%, P = 0.001) and had a higher grade of sacroiliitis (90%, 84% vs 51%, P < 0.001). Similar differences were detected in the comparison of ASP to axPsA and in a regression model. Conclusion: AS patients, with or without psoriasis, seem to be different demographically, genetically, clinically and radiographically from axPsA patients. axPsA seems to be a distinct entity.

KW - ankylosing

KW - arthritis

KW - axial

KW - psoriatic

KW - spondylitis

(Video) GRAPPA scientific program on psoriatic disease approaching the disease by domain Rheuma

UR - http://www.scopus.com/inward/record.url?scp=85085264064&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/kez457

DO - 10.1093/rheumatology/kez457

M3 - Article (Contribution to journal)

C2 - 31593590

AN - SCOPUS:85085264064

VL - 59

SP - 1340

EP - 1346

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 6

ER -

Feld J, Ye JY, Chandran V, Inman RD, Haroon N, Cook R et al. Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis? Rheumatology. 2020 Jun 1;59(6):1340-1346. https://doi.org/10.1093/rheumatology/kez457

FAQs

Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis? ›

Axial psoriatic arthritis is different demographically compared with ankylosing spondylitis with and without psoriasis. Axial psoriatic arthritis is associated with worse peripheral arthritis and less back pain. Axial psoriatic arthritis and ankylosing spondylitis with psoriasis seem to be two different diseases.

Is psoriatic arthritis and ankylosing spondylitis the same thing? ›

Psoriatic arthritis (PsA) usually occurs in people with psoriasis, an autoimmune condition that causes cells to develop rapidly, leading to various skin symptoms. Ankylosing spondylitis (AS) is a type of arthritis that mainly affects the spine and lower back, though the effects can extend throughout the body over time.

What does ankylosing spondylitis have in common with psoriatic arthritis? ›

Ankylosing spondylitis (AS) and psoriatic arthritis (PsA) are both forms of arthritis that cause joint swelling, stiffness, and pain. In AS, these symptoms strike predominantly in the back and sacroiliac joints (where the spine connects with the pelvis), though other joints can be involved.

Is ankylosing spondylitis associated with psoriasis? ›

Ankylosing spondylitis is an inflammatory arthritis that predominantly affects the axial joints and is often associated with extra-articular manifestations including psoriasis.

What is axial psoriatic arthritis? ›

Psoriatic arthritis-a heterogeneous, inflammatory, musculoskeletal disease that can cause permanent damage to both peripheral and axial joints-is the most common comorbidity of psoriasis. Axial disease occurs in 25% to 70% of patients with PsA, with some patients exclusively experiencing axial joint involvement.

What is axial involvement? ›

Axial involvement was defined as physician-reported presence of spinal involvement at enrollment, or radiograph or MRI showing sacroiliitis. Both groups of patients were similar in sex, race, BMI, disease duration, presence of dactylitis and prevalence of most comorbidities.

Can you have psoriatic arthritis without psoriasis? ›

Answer: Yes, it is certainly possible to have PsA with no psoriasis/skin symptoms. For the majority of people with PsA, psoriasis precedes the onset of arthritic symptoms, but some people develop the skin disease after the onset of arthritis. So, there may be a period of arthritis without psoriasis.

What can ankylosing spondylitis be confused with? ›

Some of the symptoms or conditions that mimic ankylosing spondylitis include:
  • Chronic Lower Back Pain. ...
  • Reactive Arthritis. ...
  • Fibromyalgia. ...
  • Psoriatic Arthritis. ...
  • Enteropathic Arthritis. ...
  • DISH.
8 Nov 2019

Can you have psoriatic arthritis with a negative HLA b27? ›

Among the 44 patients studied, thirty-two were negative for HLA-B27 (72.7%). The antigen's value has varied from 0,1 to 99,1 with an average of 27,85 ± 29,3. Positive HLA-B27 had significant correlation with male gender (p=0,004).
...
Table 1.
Demographic and social datan%
Gender
Male2556,8
Female1943,2
Race
18 more rows

What is the most severe type of psoriatic arthritis? ›

Joints in the arms, legs, hands, and feet may also be involved. The most severe and least common type of psoriatic arthritis is called arthritis mutilans. Fewer than 5 percent of individuals with psoriatic arthritis have this form of the disorder.

Is psoriatic arthritis caused by psoriasis? ›

Psoriasis. Having psoriasis is the single greatest risk factor for developing psoriatic arthritis. Family history. Many people with psoriatic arthritis have a parent or a sibling with the disease.

Does ankylosing spondylitis start suddenly? ›

The symptoms of ankylosing spondylitis (AS) usually develop slowly over several months or years. The symptoms may come and go, and improve or get worse, over many years. AS usually first starts to develop between 20 to 30 years of age.

What are the symptoms of axial spondyloarthritis? ›

The most common symptom of axial spondyloarthritis (axSpA) is pain in the lower back. Some people also have pain, stiffness, and limited mobility outside the spine, such as in the hips, knees, and heels.

Does psoriatic arthritis affect the spine? ›

Psoriatic arthritis tends to develop in the large joints, particularly in the hands and feet. However, it can also affect the spine, causing pain in the back and pelvic area. Psoriatic arthritis is most common in people with psoriasis or individuals with a family history of the disease.

How quickly does ankylosing spondylitis progress? ›

There is no single pattern of progression that applies to everyone with AS, but some of the common ways the disease can progress are described below. Ankylosing spondylitis is rarely diagnosed early, and the interval between the first symptoms and diagnosis may take, on average, 4-9 years.

Is ankylosing spondylitis the same as axial spondyloarthritis? ›

To clear things up, Ankylosing Spondylitis (AS) is actually the same as Axial Spondyloarthritis (AxSpA), but only one of the 2 subgroups of AxSpA. AS is known as radiographic AxSpA, whereas the other subgroup is known as non-radiographic.

Is axial spondyloarthritis autoimmune? ›

Doctors and researchers still have a lot to learn about the what causes axial spondyloarthritis. “It's a combination autoimmune and inflammatory disease, meaning the innate and adaptive immune systems [the body's first- and second-line defenses] are both involved,” explains Dr.

Is psoriatic arthritis axial or peripheral? ›

Psoriatic arthritis—a heterogeneous, inflammatory, musculoskeletal disease that can cause permanent damage to both peripheral and axial joints—is the most common comorbidity of psoriasis. Axial disease occurs in 25% to 70% of patients with PsA, with some patients exclusively experiencing axial joint involvement.

What are axial symptoms? ›

Axial spondyloarthritis (axSpA) is a rheumatological condition that affects the axial joints (joints of the spine, chest, and pelvis). The primary symptoms include back pain, fatigue, joint pain, heel pain, sleep problems, and abdominal pain.

What is axial disease? ›

Axial spondyloarthritis (axSpA) is a type of arthritis. It mostly causes pain and swelling in the spine and the joints that connect the bottom of the spine to the pelvis (sacroiliac joint). Other joints can be affected as well. It is a systemic disease, which means it may affect other body parts and organs.

How painful is Enthesitis? ›

The symptoms of enthesitis and enthesopathy are the same and can feel like generalized joint pain, or pain at a specific location near the joint. The pain gets worse with movement. For example, a person with enthesopathy in the Achilles tendon will experience worsening pain when running or walking.

How does a rheumatologist test for psoriatic arthritis? ›

To diagnose psoriatic arthritis, rheumatologists look for swollen and painful joints, certain patterns of arthritis, and skin and nail changes typical of psoriasis. X-rays often are taken to look for joint damage. MRI, ultrasound or CT scans can be used to look at the joints in more detail.

Can the Covid vaccine give you psoriasis? ›

Besides worsening of pre-existing psoriatic lesions, a de novo generalized pustular psoriasis following administration of the first dose of AstraZeneca-Oxford COVID-19 vaccine was also reported (10). Recently, Ricardo et al. reported de novo nail psoriasis triggered by Pfizer-BioNTech in a 76-year-old woman (13).

Does psoriatic arthritis show up in a blood test? ›

Psoriatic Arthritis Blood Test: HLA-B27

HLA-B27 is a blood test that looks for a genetic marker for psoriatic arthritis — a protein called human leukocyte antigen B27 (HLA-B27), which is located on the surface of white blood cells.

How does a rheumatologist diagnose ankylosing spondylitis? ›

Your rheumatologist will carry out imaging tests to examine the appearance of your spine and pelvis, as well as further blood tests. These may include: an X-ray. a MRI scan.

Can you see ankylosing spondylitis in MRI? ›

Ankylosing spondylitis is a chronic inflammatory rheumatic disorder which usually begins in early adulthood. The diagnosis is often delayed by many years. MR imaging has become the preferred imaging method for detection of early inflammation of the axial skeleton in ankylosing spondylitis.

Can ankylosing spondylitis affect the eyes? ›

Ankylosing spondylitis (AS) is a type of arthritis. It causes pain and stiffness, mainly in your spine. But it can also cause eye inflammation called uveitis. Left untreated, uveitis can harm your vision and, in some cases, lead to blindness.

What diseases are associated with HLA-B27 positive? ›

The most notable conditions among these include: ankylosing spondylitis, reactive arthritis (previously referred to as Reiter syndrome), Behçet's disease, inflammatory bowel disease, and psoriatic arthritis. These conditions fall under the umbrella of seronegative spondyloarthropathies.

Can you still have ankylosing spondylitis with negative HLA-B27? ›

Ankylosing spondylitis is strongly associated with the HLA-B27 gene. Testing is positive in over 90% of Caucasians. A negative test could be found in approximately 10% of Caucasian patients with the disease.

What does a positive HLA test mean? ›

A positive test means HLA-B27 is present. It suggests a greater-than-average risk for developing or having certain autoimmune disorders. An autoimmune disorder is a condition that occurs when the immune system mistakenly attacks and destroys healthy body tissue.

What organs does psoriatic arthritis affect? ›

You'll probably think of skin issues first, but your eyes, heart, lungs, gastrointestinal (GI) tract (stomach and intestines), liver and kidneys may also be affected. Skin. Psoriasis appears first in 60% to 80% of patients, usually followed within 10 years — but sometimes longer — by arthritis.

Does psoriatic arthritis cause tendon and ligament pain? ›

Psoriatic arthritis can cause pain and swelling along the bones that form the joints. This is caused by inflammation in the connective tissue, known as entheses, which attach tendons and ligaments to the bones. When they become inflamed it's known as enthesitis.

What is the best pain medication for psoriatic arthritis? ›

Nonsteroidal anti-inflammatory drugs (NSAIDs)

Your doctor might first recommend treating your psoriatic arthritis pain with ibuprofen (Motrin, Advil), or naproxen (Aleve). These drugs relieve pain and ease swelling in the joints. You can buy NSAIDs over the counter. Stronger versions are available with a prescription.

What are the six signs of psoriatic arthritis? ›

Here are six symptoms you should watch out for.
  • It's hard to move in the morning. ...
  • Your fingers look like warm sausages. ...
  • You have lower back pain. ...
  • Your nails have grooves and ridges. ...
  • You experience eye problems. ...
  • You're always tired.
22 Jul 2021

Where does psoriatic arthritis usually start? ›

PsA may begin in smaller joints, such as those of the fingers or toes, and progress from there. Spondylitis may be accompanied by dactylitis, or swelling of the toe or finger joints. This is sometimes called “sausage fingers.”

What percentage of psoriasis patients have psoriatic arthritis? ›

Psoriatic arthritis affects about 30% of people with psoriasis.

What is the most common presenting symptom in ankylosing spondylitis? ›

Early signs and symptoms of ankylosing spondylitis might include pain and stiffness in the lower back and hips, especially in the morning and after periods of inactivity. Neck pain and fatigue also are common. Over time, symptoms might worsen, improve or stop at irregular intervals.

Where does ankylosing spondylitis usually begin? ›

Ankylosing Spondylitis Symptoms

AS often starts in your sacroiliac joints, where your spine connects to your pelvis. It can affect places where your tendons and ligaments attach to bones. It can even cause your vertebrae to fuse together.

Where does ankylosing spondylitis usually start? ›

Ankylosing spondylitis (AS) (ank-ee-lo-zing spon-dee-li-tus) is a type of arthritis that mainly affects the back, by causing inflammation in the spine. This can make your back, rib cage and neck stiff and painful. It often starts in people who are in their late teens or 20s.

Can you have psoriatic arthritis without psoriasis? ›

Answer: Yes, it is certainly possible to have PsA with no psoriasis/skin symptoms. For the majority of people with PsA, psoriasis precedes the onset of arthritic symptoms, but some people develop the skin disease after the onset of arthritis. So, there may be a period of arthritis without psoriasis.

What can ankylosing spondylitis be confused with? ›

Some of the symptoms or conditions that mimic ankylosing spondylitis include:
  • Chronic Lower Back Pain. ...
  • Reactive Arthritis. ...
  • Fibromyalgia. ...
  • Psoriatic Arthritis. ...
  • Enteropathic Arthritis. ...
  • DISH.
8 Nov 2019

Can you have psoriatic arthritis with a negative HLA B27? ›

Among the 44 patients studied, thirty-two were negative for HLA-B27 (72.7%). The antigen's value has varied from 0,1 to 99,1 with an average of 27,85 ± 29,3. Positive HLA-B27 had significant correlation with male gender (p=0,004).
...
Table 1.
Demographic and social datan%
Gender
Male2556,8
Female1943,2
Race
18 more rows

Is psoriatic arthritis caused by psoriasis? ›

Psoriasis. Having psoriasis is the single greatest risk factor for developing psoriatic arthritis. Family history. Many people with psoriatic arthritis have a parent or a sibling with the disease.

How does a rheumatologist test for psoriatic arthritis? ›

To diagnose psoriatic arthritis, rheumatologists look for swollen and painful joints, certain patterns of arthritis, and skin and nail changes typical of psoriasis. X-rays often are taken to look for joint damage. MRI, ultrasound or CT scans can be used to look at the joints in more detail.

Can the Covid vaccine give you psoriasis? ›

Besides worsening of pre-existing psoriatic lesions, a de novo generalized pustular psoriasis following administration of the first dose of AstraZeneca-Oxford COVID-19 vaccine was also reported (10). Recently, Ricardo et al. reported de novo nail psoriasis triggered by Pfizer-BioNTech in a 76-year-old woman (13).

Does psoriatic arthritis show up in a blood test? ›

Psoriatic Arthritis Blood Test: HLA-B27

HLA-B27 is a blood test that looks for a genetic marker for psoriatic arthritis — a protein called human leukocyte antigen B27 (HLA-B27), which is located on the surface of white blood cells.

How does a rheumatologist diagnose ankylosing spondylitis? ›

Your rheumatologist will carry out imaging tests to examine the appearance of your spine and pelvis, as well as further blood tests. These may include: an X-ray. a MRI scan.

Can you see ankylosing spondylitis in MRI? ›

Ankylosing spondylitis is a chronic inflammatory rheumatic disorder which usually begins in early adulthood. The diagnosis is often delayed by many years. MR imaging has become the preferred imaging method for detection of early inflammation of the axial skeleton in ankylosing spondylitis.

What is the difference between axial spondyloarthritis and ankylosing spondylitis? ›

Axial spondyloarthritis can be considered a subset of spondyloarthritis. This type primarily affects the axial joints, which are those found in the spine, chest, and pelvis. Ankylosing spondylitis is generally considered a specific and severe subset of axial spondyloarthritis.

What is the most severe type of psoriatic arthritis? ›

Joints in the arms, legs, hands, and feet may also be involved. The most severe and least common type of psoriatic arthritis is called arthritis mutilans. Fewer than 5 percent of individuals with psoriatic arthritis have this form of the disorder.

What diseases are associated with HLA-B27 positive? ›

The most notable conditions among these include: ankylosing spondylitis, reactive arthritis (previously referred to as Reiter syndrome), Behçet's disease, inflammatory bowel disease, and psoriatic arthritis. These conditions fall under the umbrella of seronegative spondyloarthropathies.

Can you still have ankylosing spondylitis with negative HLA-B27? ›

Ankylosing spondylitis is strongly associated with the HLA-B27 gene. Testing is positive in over 90% of Caucasians. A negative test could be found in approximately 10% of Caucasian patients with the disease.

What organs does psoriatic arthritis affect? ›

You'll probably think of skin issues first, but your eyes, heart, lungs, gastrointestinal (GI) tract (stomach and intestines), liver and kidneys may also be affected. Skin. Psoriasis appears first in 60% to 80% of patients, usually followed within 10 years — but sometimes longer — by arthritis.

What are the six signs of psoriatic arthritis? ›

Here are six symptoms you should watch out for.
  • It's hard to move in the morning. ...
  • Your fingers look like warm sausages. ...
  • You have lower back pain. ...
  • Your nails have grooves and ridges. ...
  • You experience eye problems. ...
  • You're always tired.
22 Jul 2021

Where does psoriatic arthritis usually start? ›

PsA may begin in smaller joints, such as those of the fingers or toes, and progress from there. Spondylitis may be accompanied by dactylitis, or swelling of the toe or finger joints. This is sometimes called “sausage fingers.”

Videos

1. IL-17 Inhibitors in Nonradiographic Axial Spondyloarthritis
(PeerView CME)
2. Eliminating Diagnostic Delays in Psoriatic Arthritis
(CME Outfitters)
3. Spondyloarthritis Treatment & Research Presented by James Rosenbaum, MD
(SPONDYLITISdotORG)
4. Psoriatic Arthritis: Overcoming Barriers to Improve Patient Outcomes
(Rutgers Robert Wood Johnson Department of Medicine)
5. TNR: Psoriatic Arthritis Journal Club
(RheumNow)
6. Spondyloarthritis: Current Classification and the Implications for Clinical Practice
(ClevelandClinicCME)

Top Articles

Latest Posts

Article information

Author: Lakeisha Bayer VM

Last Updated: 11/15/2022

Views: 6292

Rating: 4.9 / 5 (69 voted)

Reviews: 92% of readers found this page helpful

Author information

Name: Lakeisha Bayer VM

Birthday: 1997-10-17

Address: Suite 835 34136 Adrian Mountains, Floydton, UT 81036

Phone: +3571527672278

Job: Manufacturing Agent

Hobby: Skimboarding, Photography, Roller skating, Knife making, Paintball, Embroidery, Gunsmithing

Introduction: My name is Lakeisha Bayer VM, I am a brainy, kind, enchanting, healthy, lovely, clean, witty person who loves writing and wants to share my knowledge and understanding with you.